1. Sapkal GN#., Wairagkar, N. S., Ayachit, V. M., Bondre, V. P., & Gore, M. M. (2007). Detection and isolation of Japanese encephalitis virus from blood clots collected during the acute phase of infection. The American journal of tropical medicine and hygiene, 77(6), 1139–1145.
2. Bondre, V. P., Sapkal GN#, Yergolkar, P. N., Fulmali, P. V., Sankararaman, V., Ayachit, V. M., Mishra, A. C., & Gore, M. M. (2009). Genetic characterization of Bagaza virus (BAGV) isolated in India and evidence of anti-BAGV antibodies in sera collected from encephalitis patients. The Journal of general virology, 90 (Pt 11),
3. Sapkal GN#, Bondre, V. P., Fulmali, P. V., Patil, P., Gopalkrishna, V., Dadhania, V., Ayachit, V. M., Gangale, D., Kushwaha, K. P., Rathi, A. K., Chitambar, S. D., Mishra, A. C., & Gore, M. M. (2009). Enteroviruses in patients with acute encephalitis, Uttar Pradesh, India. Emerging infectious diseases, 15(2), 295–298.
4. Sapkal GN#, S. Harini, V. M. Ayachit, P. V. Fulmali, S. A. Mahamuni, V. P. Bondre, and M. M. Gore. "Neutralization escape variant of West Nile virus associated with altered peripheral pathogenicity and differential cytokine profile." Virus research 158, no. 1-2 (2011): 130-139.
5. Fulmali, Pradip V, Sapkal GN#, Sulabha Athawale, Milind M. Gore, Akhilesh C. Mishra, and Vijay P. Bondre. " Introduction of Japanese encephalitis virus genotype I, India." Emerging infectious diseases 17, no. 2 (2011): 319.
6. Kulkarni, Reshma, Sapkal GN, Lata Mahishi, Pratip Shil, and Milind M. Gore. "Design and characterization of polytope construct with multiple B and TH epitopes of Japanese encephalitis virus." Virus research 166, no. 1-2 (2012): 77-86
7. Kulkarni, Reshma, Sapkal GN, and Milind Gore. "Evaluation of Japanese encephalitis virus polytope DNA vaccine candidate in BALB/c mice." Virus research 170, no. 1-2 (2012): 118-125.
8. Patowary, Ashok, K. V. Shamsudheen, Vinita Periwal, K. P. Kushwaha, Sapkal GN et al. "De novo identification of viral pathogens from cell culture hologenomes." BMC research notes 5, no. 1 (2012): 1-5.
9. Gangwar, Roopesh Singh, Pratip Shil, Sapkal GN, Siraj A. Khan, and Milind M. Gore. "Induction of virus-specific neutralizing immune response against West Nile and Japanese encephalitis viruses by chimeric peptides representing T-helper and B-cell epitopes." Virus research 163, no. 1 (2012): 40-50.
10. Sooryanarain, Harini, Sapkal GN, and Milind M. Gore. "Pathogenic and vaccine strains of Japanese encephalitis virus elicit different levels of human macrophage effector functions." Archives of virology 157, no. 10 (2012): 1905-1918
11. Bhatt, Girish Chandra, V. P. Bondre, Sapkal GN et al. "Changing clinico-laboratory profile of encephalitis patients in the eastern Uttar Pradesh region of India." Tropical Doctor 42, no. 2 (2012): 106-108.
12. Sudeep, A. B., V. P. Bondre, Y. K. Gurav, M. D. Gokhale, Sapkal GN, M. S. Mavale, R. P. George, and A. C. Mishra. " Isolation of Chandipura virus (Vesiculovirus: Rhabdoviridae) from Sergentomyia species of sandflies from Nagpur, Maharashtra, India." The Indian journal of medical research 139, no. 5 (2014): 769.
13. Anukumar, B., Sapkal GN, Babasaheb V. Tandale, R. Balasubramanian, and Daya Gangale. "West Nile encephalitis outbreak in Kerala, India, 2011." Journal of Clinical Virology 61, no. 1 (2014): 152-155.
14. Roy, Soumen, Daya Pavitrakar, Rashmi Gunjikar, Vijay M. Ayachit, Vijay P. Bondre, and Sapkal GN*. "Monocytes and B cells support active replication of Chandipura virus." BMC infectious diseases 16, no. 1 (2016): 1-8.
15. Bondre, Vijay P., Vasudha Sankararaman, Vijaysinh Andhare, Manisha Tupekar, and Sapkal GN*. "Genetic characterization of human herpesvirus type 1: Full-length genome sequence of strain obtained from an encephalitis case from India." The Indian journal of medical research 144, no. 5 (2016): 750.
16. Damle, R. G., A. A. Patil, V. S. Bhide, S. D. Pawar, Sapkal GN, and V. P. Bondre. "Development of a novel rapid micro-neutralization ELISA for the detection of neutralizing antibodies against Chandipura virus." Journal of virological methods 240 (2017): 1-6.
17. Shil, Pratip, Sapkal GN, Avinash A. Patil, and Annakathil B. Sudeep. "Meteorological parameters and mosquito abundance in Pashan area of Pune, India during south west monsoon and post-monsoon seasons in 2016." Journal of Mosquito Research 7 (2017).
18. Balakrishnan A, Thekkekare RJ, Sapkal G, Tandale BV. Seroprevalence of Japanese encephalitis virus & West Nile virus in Alappuzha district, Kerala. Indian J Med Res. 2017 Jul;146(Supplement):S70-S75.
19. Joshi, M. S., B. V. Tandale, M. M. Gore, S. Bhalla, Y. K. Gurav, Sapkal GN, K. P. Kushwaha, A. C. Mishra, and S. D. Chitambar. "Evidence of hepatitis A virus infection in the patients with acute encephalitis syndrome in Gorakhpur region, North India." Acta virologica 62, no. 2 (2018): 208-213
20. Deshpande, Gururaj Rao, Bipin Tilekar, Supriya L. Hundekar, Kirtee Khutwad, Rashmi S. Gunjikar, Shankar Vidhate, and Sapkal GN*. "Molecular characterization of chikungunya virus from urbanized villages of Pune, Maharashtra, India, 2016." The Indian journal of medical research 148, no. 6 (2018): 756.
21. Sapkal GN#, Pragya D. Yadav, Mahendra M. Vegad, Rajlakshmi Viswanathan, Nivedita Gupta, and Devendra T. Mourya. "First laboratory confirmation on the existence of Zika virus disease in India." Journal of Infection 76, no. 3 (2018): 314-317.
22. Shil, Pratip, Sapkal GN, Avinash A. Patil, Satish N. Gunjal, and Anakathil B. Sudeep. "Meteorological parameters and seasonal variability of mosquito population in Pune Urban Zone, India: A year-round study, 2017." Journal of Mosquito Research 8 (2018).
23. Bharadwaj, Sumit D., Rima R. Sahay, Pragya D. Yadav, Sara Dhanawade, Atanu Basu, Virendra K. Meena, Suji George, Rekha Damle, and Sapkal GN*. "Acute encephalitis with atypical presentation of rubella in family cluster, India." Emerging infectious diseases 24, no. 10 (2018): 1923.
24. Murhekar, Manoj, Ashish Bavdekar, Asha Benakappa, Sridhar Santhanam, Kuldeep Singh, Sanjay Verma, Sapkal GN et al. "Sentinel surveillance for congenital rubella syndrome—India, 2016–2017." Morbidity and Mortality Weekly Report 67, no. 36 (2018)
25. Muliyil DE, Singh P, Jois SK, Otiv S, Suri V, Varma V, Abraham AM, Raut C, Gupta M, Singh MP, Viswanathan R, Naik S, Nag V, Benakappa A, Bavdekar A, Sapkal G, Singh K, Gupta N, Verma S, Santhanam S, Mishra S, Bhatnagar A, Prasad GRV, Kolekar J, Raj N, Sabarinathan R, Sachdeva RK, George S, Chaudhary S, Verghese VP, Jagtap V, Bharadwaj M, Murhekar M. Sero-prevalence of rubella among pregnant women in India, 2017.
26. Murhekar M, Bavdekar A, Benakappa A, Santhanam S, Singh K, Verma S, Sapkal GN, Gupta N, Verghese VP, Viswanathan R, Abraham AM, Choudhary S, Deshpande GN, George S, Goyal G, Lepcha A, Mahantesh S, et al. Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017. MMWR Morb Mortal Wkly Rep. 2018
27. Sapkal GN#, Pradeep M. Sawant, and Devendra T. Mourya. "Suppl-2, M2: Chandipura Viral Encephalitis: A Brief Review." The open virology journal 12 (2018): 44.
28. Tandale, Babasaheb V., Siraj A. Khan, Komal P. Kushwaha, Helina Rahman, Milind M. Gore, Sapkal GN, Vijay P. Bondre, D. K. Srivastava, Basanta Laskar, and J. Mahanta. "Effectiveness of Japanese encephalitis SA 14-14-2 live attenuated vaccine among Indian children: Retrospective 1: 4 matched case-control study." Journal of infection and public health 11, no. 5 (2018): 713-719.
29.Gurav YK, Yadav PD, Gokhale MD, Chiplunkar TR, Vishwanathan R, Patil DY, Jain R, Shete AM, Patil SL, Sarang GD, Sapkal GN, Andhare MD, Sale YR, Awate PS, Mourya DT. Kyasanur Forest Disease Prevalence in Western Ghats Proven and Confirmed by Recent Outbreak in Maharashtra, India, 2016. Vector Borne Zoonotic Dis. 2018 Mar;18(3):164-172. doi: 10.1089/vbz.2017.2129. Epub 2018 Jan 16. PMID: 29336707
30. Yadav, Pragya D., Bharati Malhotra, Sapkal GN, et al. "Zika virus outbreak in Rajasthan, India in 2018 was caused by a virus endemic to Asia." Infection, Genetics and Evolution 69 (2019): 199-202.
31. Sudeep, A. B., R. S. Gunjikar, Y. S. Ghodke, K. Khutwad, and Sapkal GN*. "Temperature sensitivity and environmental stability of Chandipura virus." VirusDisease 30, no. 2 (2019): 214-218.
32. Pawar, Shailesh D., Sachin S. Keng, Deeksha S. Tare, Anil L. Thormothe, Sapkal GN,."A virus precipitation method for concentration & detection of avian influenza viruses from environmental water resources & its possible application in outbreak investigations." The Indian journal of medical research 150, no. 6 (2019): 612.
33. Murhekar MV, Kamaraj P, Kumar MS, Khan SA, Allam RR, Barde P, Dwibedi B, Kanungo S, Mohan U, Mohanty SS, Roy S, Sagar V, Savargaonkar D, Tandale BV, Topno RK, Sapkal G, Kumar CPG, Sabarinathan R, Kumar VS, Bitragunta S, Grover GS, Lakshmi PVM, Mishra CM, Sadhukhan P, Sahoo PK, Singh SK, Yadav CP, Bhagat A, Srivastava R, Dinesh ER, Dutta S, Toteja GS, Gupta N, Mehendale SM. Burden of dengue infection in India, 2017: a cross-sectional population based serosurvey. Lancet Glob Health. 2019 Aug;7(8):e1065-e1073. doi: 10.1016/S2214-109X(19)30250-5. Epub 2019 Jun 11. PMID: 31201130.
34. Singh R, Gupta V, Malhotra B, Singh S, Ravindran P, Meena D, Gupta J, Mathur VK, Mathur RP, Singh S, Sharma P, Sharma H, Bhandari S, Gupta N, Sapkal G, Mourya DT, Speer MD. Cluster containment strategy: addressing Zika virus outbreak in Rajasthan, India. BMJ Glob Health. 2019 Sep 5;4(5):e001383. doi: 10.1136/bmjgh-2018-001383. PMID: 31565402; PMCID:
35. Viswanathan, Rajlakshmi, Suji George, Manoj V. Murhekar, Asha Mary Abraham, Mini P. Singh, Santoshkumar M. Jadhav, Vijayalakshmi Nag, Sapkal GN et al. "Comparison of two commercial ELISA kits for detection of rubella specific IgM in suspected congenital rubella syndrome cases and rubella IgG antibodies in a serosurvey of pregnant women." Diagnostic microbiology and infectious disease 94, no. 3 (2019): 243-247
36. Sapkal GN#, Anil Yadav, Gururaj Rao Deshpande, Pragya D. Yadav, Ketki Deshpande, Darpan Phagiwala, Rajlaxmi Jain et al. "Development of equine antisera with high neutralizing activity against SARS-CoV-2." (2020).
37. Malhotra, Bharti, Veenu Gupta, Pratibha Sharma, Ruchi Singh, Himanshu Sharma, Madhavi Vyas, Ravi P. Mathur Sapkal GN et al. "Clinico-epidemiological and genomic profile of first Zika Virus outbreak in India at Jaipur city of Rajasthan state." Journal of Infection and Public Health 13, no. 12(2020): 1920-1926.
38. Naik S, Robinson ML, Alexander M, Chandanwale A, Sambarey P, Kinikar A, Bharadwaj R, Sapkal GN*, Chebrolu P, Deshpande P, Kulkarni V, Nimkar S, Mave V, Gupta A, Mathad J. Intensified Short Symptom Screening Program for Dengue Infection during Pregnancy, India. Emerg Infect Dis. 2020 Apr;26(4):738-743. doi: 10.3201/eid2604.191476. PMID: 32186485; PMCID: PMC7101120.
39. Murhekar M, Verma S, Singh K, Bavdekar A, Benakappa N, Santhanam S, Sapkal G, Viswanathan R, Singh MP, Nag VL, Naik S, Ashok M, Abraham AM, Shanmugasundaram D, Singh P, Gadepalli R, Vaid N, Kadam S, Shah S, Mahantesh S, Gowda VK, Haldar P, Aggarwal MK, Gupta N. Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance. PLoS Negl Trop Dis. 2020 Feb 3;14(2):e0007982. doi: 10.1371/journal.pntd.0007982. PMID: 32012162; PMCID: PMC6996802.
40. Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Mitra A, Girish Kumar CP, Luke HE, Ranganathan UD, Babu S, Sekar K, Yadav PD, Sapkal GN et al. Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):48-60. doi: 10.4103/ijmr.IJMR_3290_20. PMID: 32952144; PMCID: PMC7853249.
41. Bhatnagar, Tarun, Gururaj Rao Deshpande, Bharti Malhotra, Padinjaremattathil Thankappan Ullas, Rutuja Dhawde, Sharada Sharma, Mukesh Mittal, Sapkal GN et al. "No evidence of recent Zika virus transmission among the cohort of pregnant women after the 2018 outbreak in Jaipur city, Rajasthan, India, 2019-20." Journal of Clinical Virology Plus (2021): 100031
42. Hasan AZ, Kumar MS, Prosperi C, Thangaraj JWV, Sabarinathan R, Kumar S, Duraiswamy A, Kaduskar O, Bhatt V, Deshpande GR, Ullas PT, Sapkal GN et al. Implementing Serosurveys in India: Experiences, Lessons Learned, and Recommendations. Am J Trop Med Hyg. 2021 Oct 4: tpmd210401. doi: 10.4269/ajtmh.21-0401. Epub ahead of print. PMID: 34607310.
43. Tandale, Babasaheb V., Vijay P. Bondre, Sapkal GN, Varanasi Gopalkrishna, Yogesh K. Gurav, R. Kondal Rao, Mohiuddin S. Qazi et al. "Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India." Journal of Clinical Virology 144 (2021): 104970.
44. Prosperi C, Kaduskar O, Bhatt V, Hasan AZ, Vivian Thangaraj JW, Kumar MS, Sabarinathan R, , Sharma S, Moss WJ, Sangal L, Gupta N, Murherkar MV, Mehendale SM, Sapkal GN* et al. Diagnostic Accuracy of Dried Blood Spots Collected on HemaSpot HF Devices Compared to Venous Blood Specimens To Estimate Measles and Rubella Seroprevalence. mSphere. 2021 Aug 25;6(4):e0133020.
45. Kaduskar O, Bhatt V, Prosperi C, Hayford K, Hasan AZ, Deshpande GR, Tilekar B, Vivian Thangaraj JW, Kumar MS, Gupta N, Murhekar MV, Moss WJ, Mehendale SM, Sangal L, Sapkal GN*. Optimization and Stability Testing of Four Commercially Available Dried Blood Spot Devices for Estimating Measles and Rubella IgG Antibodies. mSphere. 2021 Aug 25;6(4):e0049021. doi: 10.1128/mSphere.00490-21. Epub 2021 Jul 14. PMID: 34259563; PMCID: PMC8386427
46. Potdar V, Cherian SS, Deshpande GR, Ullas PT, Yadav PD, Choudhary ML, Gughe R, Vipat V, Jadhav S, Patil S, Nyayanit D, Majumdar T, Walimbe A, Gaikwad S, Dighe H, Shete-Aich A, Mohandas S, Chowdhury D, Sapkal GN, Basu A, Gupta N, Gangakhedkar RR, Giri S, Dar L, Jain A, Malhotra B, Abraham P; National Influenza Centre (NIC) Team: Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):255-260. DOI: 10.4103/ijmr.IJMR_1058_20. PMID: 32362650; PMCID: PMC7366550.
47. Sarkale P, Patil S, Yadav PD, Nyayanit DA, Sapkal GN, Baradkar S, Lakra R, Shete-Aich A, Prasad S, Basu A, Dar L, Vipat V, Giri S, Potdar V, Choudhary ML, Praharaj I, Jain A, Malhotra B, Gawande P, Kalele K, Gupta N, Cherian SS, Abraham P. First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):244-250. DOI: 10.4103/ijmr.IJMR_1029_20. PMID: 32362649; PMCID: PMC7366528.
48. Mohandas S, Jain R, Yadav PD, Shete-Aich A, Sarkale P, Kadam M, Kumar A, Deshpande G, Baradkar S, Patil S, Sapkal GN, Mali D, Salve M, Patil D, Majumdar T, Suryawanshi A, Kaushal H, Lakra R, Dighe H, Gupta N, Abraham P, Gangakhedkar RR. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection. Indian J Med Res. 2020 May; 151(5):479-482. DOI: 10.4103/ijmr.IJMR_2235_20. PMID: 32611917; PMCID: PMC7530454.
49. Gupta, N., Potdar, V., Praharaj, I., Giri, S., Sapkal GN., Yadav, P., Choudhary, M. L., Dar, L., Sugunan, A. P., Kaur, H., Munivenkatappa, A., Shastri, J., et al. (2020). Authors' response. The Indian journal of medical research, 151(5), 496. https://doi.org/10.4103/0971-5916.286255
50. Sapkal GN#, Shete-Aich A, Jain R, Yadav PD,Sarkale P, Lakra R, Baradkar S, Deshpande GR, Mali D, Tilekar BN, Majumdar T, Kaushal H, Gurav Y, Gupta N, Mohandas S, Deshpande K, Kaduskar O, Salve M, Patil S, Gaikwad S, Sugunan AP, Ashok M, Giri S, Shastri J, Abraham P, Gangakhedkar RR; $ Waghmare A., Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449..
51. Deshpande GR, Sapkal GN*, Tilekar BN, Yadav PD,Gurav Y, Gaikwad S, Kaushal H, Deshpande KS, Kaduskar O, Sarkale P, Baradkar S, Suryawanshi A, Lakra R, Sugunan AP, Balakrishnan A, Abraham P, Salve P. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):82-87. DOI:10.4103 /ijmr.IJMR_ 2382_20. PMID: 32859866; PMCID: PMC7853248.
52. Nyayanit DA, Sarkale P, Baradkar S, Patil S, Yadav PD, Shete-Aich A, Kalele K, Gawande P, Majumdar T, Jain R, Sapkal GN. Transcriptome & viral growth analysis of SARS-CoV-2-infected Vero CCL-81 cells. Indian J Med Res. 2020 Jul & Aug; 152(1 & 2):70-76.
53. Agarwal A, Mukherjee A, Kumar G, Chatterjee P, [……] Sapkal GN et al. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicenter randomised controlled trial (PLACID Trial). BMJ. 2020 Oct 22; 371:m3939. DOI: 10.1136/bmj.m3939. Erratum in: BMJ. 2020 Nov 3; 371:m4232. PMID: 33093056; PMCID: PMC7578662.
54. Gupta N Potdar V, Praharaj I, Giri S, Sapkal GN, , et al. Pandemic SARS-CoV-2 laboratory preparedness in India: An opportunity beyond diagnostics Response. Indian J Med Res. 2020, 151 (5): 496-496.
55. Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Vamshi Sarangi V, Ganneru B, Sapkal GN, Yadav PD, Abraham P, et al A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine-BBV152. medRxiv DOI: https://doi.org/10.1101/2020.12.11. 20210419.
56. Mohandas S, Yadav PD, Shete A, Sapkal GN et al. Immunogenicity and protective efficacy of BBV152: a whole virion inactivated SARS CoV-2 vaccine in the Syrian hamster model. Research Square 2020. DOI: https://doi.org/10.21203/rs.3.rs-76768/v1
57. Potdar V, Choudhary ML, Bhardwaj S, Ghuge R, Sugunan AP, Gurav Y, Yadav PD, Shete A, Tomar S, Anukumar B, Kaushal H, Sapkal G, Basu A, Cherian S, Abraham P. Respiratory virus detection among the overseas returnees during the early phase of COVID-19 pandemic in India. Indian J Med Res. 2020 May;151(5):486-489. doi: 10.4103/ijmr.IJMR_638_20. PMID:
58. Yadav, Pragya, Sreelekshmy Mohandas, Prasad Sarkale, Dimpal Nyayanit, Anita Shete, Rima Sahay, Varsha Potdar, Sapkal GN et al. "Isolation of SARS-CoV-2 B. 1.1. 28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model." bioRxiv (2021).
59. Sapkal GN#, D. Yadav, and R. Sahay. "Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutsera of Covishield™ vaccinees and COVID-19." (2021).
60. Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal GN et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 Jan 21:S1473-3099(20)30942-7. DOI: 10.1016/S1473-3099(20)30942-7. Epub ahead of print. PMID: 33485468; PMCID: PMC7825810.
61. Mohandas S, Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal GN, et al. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience. 2021 Feb 19; 24(2):102054. DOI: 10.1016/j.isci.2021.102054. Epub 2021 Jan 9. PMID: 33521604; PMCID: PMC7829205.
62. Yadav PD, Ella R, Kumar S, Sapkal GN et al. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 12, 1386 (2021).
63. Ella R, Reddy S, Jogdand H, Sarangi V, Ganneru B, Prasad S, Das D, Raju D, Praturi U, Sapkal GN et al Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021
64. Ganneru B, Jogdand H, Daram VK, Das D, Molugu NR, Prasad SD, Kannappa SV, Ella KM, Ravikrishnan R, Awasthi A, Jose J, Rao P, Kumar D,Ella R, Abraham P, Yadav PD, Sapkal GN. et al. Th1 Skewed immune response of Whole Virion Inactivated SARS CoV 2 Vaccine and its safety evaluation. Iscience. 2021 Mar.
65. Deshpande GR, Kaduskar O, Deshpande K, Bhatt V, Yadav P, Gurav Y, Patsuthe S, Dange V, Kumar S, Gurav S, Chate S, Abraham P, Sapkal GN*. Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2. Int J Infect Dis. 2021 Sep 17; 112:103-110.
66. Kant, Rajni, Gaurav Dwivedi, Kamran Zaman, Rima R. Sahay, Sapkal GN et al. "Immunogenicity and safety of a heterologous prime-boost COVID-19 vaccine schedule: ChAdOx1 vaccine Covishield followed by BBV152 Covaxin." Journal of Travel Medicine (2021).
67. Deshpande K, Pt U, Kaduskar O, Vijay N, Rakhe A, Vidhate S, Khutwad K, Deshpande GR, Tilekar B, Saka S, Gadekar K, Patil R, Yadav P, Potdar V, Gurav Y, Gupta P, Kaur H, Narayan J, Sapkal GN*, Abraham P. Performance assessment of seven SARS-CoV-2 IgG enzyme-linked immunosorbent assays. J Med Virol. 2021 Dec;93(12):6696-6702. doi: 10.1002/jmv.27251. Epub 2021 Aug 10. PMID: 34331713; PMCID: PMC8426713.
68. Mammen JJ, Kumar S, Thomas L, Kumar G, Zachariah A, Jeyaseelan L, Peter JV, Barge V, Bajpayee A, Malhotra P, Singh N, Tambe M, Patel TC, Nagori I, Jha PR, Babu KVS, Aparna C, Panjwani SJ, Natarajan M, Baldi M, Khadke VK, Dua S, Singh R, Sharma A, Sharma J, Gokhale YA, Yadav PD, Sapkal GN et al. Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial. BMJ Open. 2021 Oct 4;11(10):e050571. doi: 10.1136/bmjopen-2021-050571. PMID: 34607865; PMCID: PMC8491003.
69. Sapkal GN#, Pragya D. Yadav, Raches Ella, Priya Abraham, Deepak Y. Patil, Nivedita Gupta, Samiran Panda, V. Krishna Mohan, and Balram Bhargava. "Neutralization of B. 1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID-19 vaccine Covaxin." Journal of Travel Medicine (2021).
70. Munivenkatappa A, Sahay RR, Deshpande GR, Patil DY, Shete AM, Sapkal GN et al. A case with SARS-CoV-2 reinfection from India. Indian J Med Microbiol. 2021 Nov 15:S0255-0857(21)04647-8. doi: 10.1016/j.ijmmb.2021.09.010. Epub ahead of print. PMID: 34789389; PMCID: PMC8590946.
71. Deshpande, G. R., Bhukya, P. L., Yadav, P. D., Salunke, A., Patil, C., Tilekar, B. N., Rakhe, A., Srivastava, R., Gurav, Y. K., Potdar, V., Abraham, P., & Sapkal GN*. (2021). Comparison of neutralizing antibody response in first and second waves of SARS CoV-2 pandemic in India. Journal of travel medicine, taab196.
72.Yadav, P., Mohandas, S., Sarkale, P., Nyayanit, D., Shete, A., Sahay, R., Potdar, V., Baradkar, S., Gupta, N., Sapkal GN, Abraham, P., Panda, S., & Bhargava, B. (2021). Isolation of SARS-CoV-2 B.1.1.28.2 (P2) variant and pathogenicity comparison with D614G variant in hamster model. Journal of infection and public health, 15(2), 164–171. Advance online publication. https://doi.org/10.1016/j.jiph.2021.12.009
73. Sapkal GN#, Yadav PD, Ella R, Deshpande GR, Sahay RR, Gupta N, Vadrevu KM, Abraham P, Panda S, Bhargava B. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 1;28(4):
74. Yadav PD, Sapkal GN#, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, Abraham P, Panda S, Bhargava B. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 Oct 11;28(7): taab104. doi: 10.1093/jtm/taab104. PMID: 34230972; PMCID: PMC8344909.
75. Yadav PD, Sapkal GN#, Abraham P, Deshpande G, Nyayanit DA, Patil DY, Gupta N, Sahay RR, Shete AM, Kumar S, Panda S, Bhargava B. Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1. Clin Infect Dis. 2021 May 24: ciab483. doi: 10.1093/cid/ciab483. Epub ahead of print. PMID: 34036309.
76. Mohandas S, Yadav PD, Shete A, Nyayanit D, Sapkal G, Lole K, Gupta N. SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters. Viruses. 2021 Sep 5;13(9):1773. doi: 10.3390/v13091773. PMID: 34578354; PMCID: PMC8473140.
77. Sapkal GN#, Yadav PD, Sahay RR, Deshpande G, Gupta N, Nyayanit DA, Patil DY, Shete AM, Kumar S, Abraham P, Panda S, Bhargava B. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 Oct 11;28(7):taab119. doi: 10.1093/jtm/taab119. PMID: 34343316; PMCID: PMC8385819.
78. Yadav PD, Sahay RR, Sapkal G, Nyayanit D, Shete AM, Deshpande G, Patil DY, Gupta N, Kumar S, Abraham P, Panda S, Bhargava B. Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152. J Travel Med. 2021 Dec 29;28(8): taab154. doi: 10.1093/jtm/taab154. PMID: 34581415; PMCID: PMC8500129.
79. Sapkal G#, Yadav PD, Ella R, Abraham P, Patil DY, Gupta N, Panda S, Mohan VK, Bhargava B. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 Oct 11;28(7): taab077. doi: 10.1093/jtm/taab077. PMID: 34002240; PMCID: PMC8194512.
80. Ella R, Reddy S, Blackwelder W, Potdar V, Yadav P, Sarangi V, Aileni VK, Redkar S, Mohapatra S, Pandey A, Ranganadin P, Gumashta R, Multani M, Mohammad S, Bhatt P, Kumari L, Sapkal G,; COVAXIN Study Group. Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial. Lancet. 2021 Dec 11;398(10317)
81. Yadav PD, Sapkal GN#, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Bhargava B, Mohan VK. Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees. Clin Infect Dis. 2022 Jan 29;74(2):366-368. doi: 10.1093/cid/ciab411. PMID: 33961693
82. Yadav PD, Niyas VKM, Arjun R, Sahay RR, Shete AM, Sapkal GN, D Pawar S, Patil DY, Gupta N, Abraham P. Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during the second wave of COVID-19 pandemic. J Med Virol. 2022 Jan 31. doi: 10.1002/jmv.27638.
83. Sahay RR, Patil DY, Sapkal GN, Deshpande GR, Shete AM, Nyayanit DA, Kumar S, Yadav PD. SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera. J Infect. 2022 Feb 19:S0163-4453(22)00082-2. doi: 10.1016/j.jinf.2022.02.018. Epub ahead of print. PMID: 35192896; PMCID: PMC8857767.
84. Yadav PD, Sapkal GN, Sahay RR, Patil DY, Deshpande GR, Jain R, Nyayanit DA, Shete AM, Suryawanshi A, Nandapurkar A, Gurav YK, Abraham P. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees. J Infect. 2022 Mar 19:S0163-4453(22)00170-0. doi: 10.1016/j.jinf.2022.03.016.
85. Deshpande GR, Yadav PD, Abraham P, Nyayanit DA, Sapkal GN,Booster dose of the inactivated COVID-19 vaccine BBV152 (Covaxin) enhances the neutralizing antibody response against alpha, Beta, Delta and omicron variants of concern. J Travel Med. 2022 Mar 24:taac039. doi: 10.1093/jtm/taac039. Epub ahead of print. PMID: 35325176.
86. Mourya, Devendra T., Pratip Shil, Sapkal GN. "Zika virus: Indian perspectives." The Indian journal of medical research 143, no. 5 (2016): 553. (Review)
87. Mourya DT, Sapkal GN, Yadav PD. Difference in vector ticks dropping rhythm governs the epidemiology of Crimean-Congo hemorrhagic fever & Kyasanur forest disease in India. Indian J Med Res. 2016 Oct;144(4):633-635. doi: 10.4103/0971-5916.200892. PMID: 28256476; PMCID: PMC5345314. (Review)
88. Yadav PD, Sapkal GN, Sahay RR. Indian efforts towards the interventions of dual use of science and technology. IJMR Hindi Patrika (Review)
89. Kulkarni, Reshma, Sapkal GN, Himanshu Kaushal, and Devendra T. Mourya. "Suppl-2, M8: Japanese encephalitis: A brief review on Indian perspectives." The open virology journal 12 (2018): 121. (Review)
90. Gajanan N. Sapkal,* Pradeep M. Sawant, and Devendra T. Mourya Chandipura Viral Encephalitis: A Brief Review Open Virol J. 2018; 12: 44–51.Published online 2018 Aug 31. doi: 10.2174/ 187435790181 2010044 (Review)
91. George S, Viswanathan R, Sapkal GN*. Molecular aspects of the teratogenesis of rubella virus. Biol Res. 2019 Aug 28;52(1):47. doi: 10.1186/s40659-019-0254-3. . (Review)
92. Gupta, N., Potdar, V., Praharaj, I., Giri, S., Sapkal GN., Yadav, P., Choudhary, et al. (2020). Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. The Indian journal of medical research, 151(2 & 3), 216–225. https://doi.org/10.4103/ijmr. IJMR_594_20 (Review)
93. Gupta, Nivedita, Pragya D. Yadav, Deepak Y. Patil, and Sapkal GN. "Preparedness of public health-care system for Zika virus outbreak: An Indian perspective." Journal of infection and public health 13, no. 7 (2020): 949-955. (Review)
94. Mourya DT, Sapkal GN, Yadav PD, M Belani SK, Shete A, Gupta N. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):172-176. DOI: 10.4103/ijmr.IJMR_763_20. PMID: 32242878; PMCID: PMC7357401. (Review)
95. Pragya D. Yadav#*, Gajanan N. Sapkal#, Rima R. Sahay#, Varsha A. Potdar, Gururaj R Pradeep Awate, Bharti Malhotra, Priya Abraham. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns, Journal of Infection
96. Pragya D. Yadav#*, Gajanan N. Sapkal#, Rima R. Sahay#, Varsha A. Potdar, Gururaj R Pradeep Awate, Bharti Malhotra, Priya Abraham. Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concerns, Journal of Infection
97. Ojas Kaduskar, Yogesh Gurav, Ketki Deshpande, Gururaj Rao Deshpande, Pragya D. Yadav, Aparna Rakhe, Bipin Tilekar, Prasad Gomade, Asha Salunke, Chetan Patil, Varsha Dange, Pavan Salvi, Sudhir Patsuthe, Priya Abraham, Gajanan Sapkal* Understanding dynamics of IgM and IgG antibody in COVID-19 positive patients (IJMR)
98. Mohandas S, Yadav PD, Sapkal G, Shete AM, Deshpande G, Nyayanit DA, Patil D, Kadam M, Kumar A, Mote C, Jain R. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern. EBioMedicine. 2022 Apr 8; 79:103997. doi: 10.1016/j.ebiom.2022.103997. Epub ahead of print. PMID: 35405385; PMCID: PMC8993158.
99. George, Suji, Gururaj Rao Deshpande, and Sapkal GN* "Interferons and their role in viral infection." In Dynamics of immune activation in viral diseases, pp. 61-80. Springer, Singapore, 2020. (Book Chapter)
